{"filing": {"accession": "0001683168-26-007017", "cik": "0001402328", "ticker": "SBFM", "company_name": "Sunshine Biopharma Inc.", "form_type": "424B3", "filing_type": "424B3", "filing_date": "2026-09-08", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826007017/0001683168-26-007017-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826007017/0001683168-26-007017-index.htm", "period_of_report": null}, "html_url": "/api/filings/000168316826007017/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 1, "table_type": "financial", "caption": null, "header_text": "Per\nShareTotal"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "(1)Represents current exercise\n price of the Series B Warrants."}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": "PROSPECTUS SUMMARY1"}, {"table_index": 10, "table_type": "exhibit_index", "caption": null, "header_text": "\u00b7our Annual Report onForm 10-Kfor the fiscal year ended December 31, 2025 filed with the SEC on April\n3, 2026;"}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 43}